Efficacy of DAPA on eGFR and clinical parameters
eGFR was significantly decreased at 1 month and 2 months after initiation of DAPA treatment (Fig. Changes in eGFR and urinary protein levels before and after dapagliflozin treatment. (Changes in serum uric acid and hemoglobin levels before and after dapagliflozin treatment. (